While cholesterol efflux increased in response to simvastatin , bezafibrate and combination treatment ( +@ to +@ % ; anova , P = @ ) , HDL antioxidative capacity ( P = @ ) and HDL anti-inflammatory capacity ( P = @ ) did not change significantly .